Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia

NCT01614093 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Oxytocin
DRUG: Placebo

Sponsor

University of Maryland, Baltimore